Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
253.00    -7.00 (-2.69%)
Bid:
253.00
Ask:
262.00
Spread: 9.00 (3.557%)
Market Cap: £226.58m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

4 Nov 2020 07:00

RNS Number : 1523E
Wilmington PLC
04 November 2020
 

4 November 2020

Wilmington plc

('Wilmington' or 'the Group')

Trading Update

 

Wilmington plc, the provider of data, information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas today announces an update on trading for the three months to 30 September 2020. This statement is being made ahead of its Annual General Meeting ('AGM') which is taking place later today. The AGM is taking place as a closed meeting due to the restrictions imposed in response to Covid-19.

 

Trading Update

 

The Board is pleased to announce that financial results for the quarter have been encouraging and were ahead of management's previous expectations. Adjusted PBT was ahead of the corresponding period in the last financial year despite revenue being down around 6% on an underlying basis at constant currency due to the inability of the Group to run face-to-face training and events in the period.

 

The Group's Preliminary Results announced on 17 September 2020 demonstrated the extent to which the digital transformation of face-to-face events and training to virtual formats had been successful. The speed with which this transformation was delivered helped to mitigate a significant element of the potential first quarter revenue impact from Covid-19. Decisive action to reduce costs has also continued - the savings in direct costs as a result of this transition were augmented by an overhead reduction exercise that was undertaken over the summer resulting in the improved year-on-year profitability.

 

Each of the Group's three divisions has seen trading ahead of internal expectations. Notable performances were seen in our core subscription-led data businesses, which make up around 50% of Group revenues and which have continued to hold up well during the pandemic. Additionally, in Compliance, ICA Singapore has seen good registrations for new qualifications and in Professional, the investment banking training business was able to convert its summer intake programme to virtual formats and hence deliver revenue in line with the prior year.

 

Cashflow in the quarter was also better than previously expected with net debt as at 30 September 2020 of £28.0m (30 September 2019: £41.2m). In October, to secure its headroom, the Group extended by twelve months the term on its existing £65.0m revolving credit facility by exercising the pre-existing option that it had to do so. The facility will now expire on 3 July 2024.

 

Outlook

 

Following the strong first quarter trading performance the Group is on track to at least achieve the expectations for the half year that it set out in the Preliminary Results announcement on 17 September 2020. This is for revenue and profit in the first half to be in line with that achieved in the second half of the year to 30 June 2020.

 

Predictions for second half performance remain difficult at this current time due to the uncertainty over the extent to which the Group will be able to run face-to-face events in that period. Recent lockdowns and developments globally in the spread of Covid-19 are likely to delay the resumption of face-to-face activities and it is not possible to say at this stage when that resumption will be. The Group is currently in active discussions with customers over its key H2 events such as RISE National and is considering all alternatives around format and timing.

 

In the Preliminary Results announcement we set out a range of potential outcomes for H2 depending on whether or not we could run face-to-face events and training. Recent trading experience leads us to believe that a fully virtual H2 would deliver better revenue and profitability than we guided to at that time as the lower end of the potential range. So whilst the chances of that scenario occurring have increased in recent weeks as the pandemic has developed, we feel increasingly confident in our ability to mitigate some of the associated financial effects of that potential outcome.

 

The Group plans to announce its Interim Results for the six months ended 31 December 2020 on Thursday 18 February 2021.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

Wilmington plc 020 7490 0049

 

Mark Milner, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting 020 3727 1000

Charles Palmer / Dwight Burden / Emma Hall / Debbie Oluwaseyi Sonaike

 

 

Notes to Editors 

Wilmington is the recognised knowledge leader and partner of choice for data, information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington plc is listed on the main market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOVNRRNUARAA
Date   Source Headline
1st Mar 20171:58 pmRNSVoting Rights and Capital
24th Feb 20172:29 pmRNSDirector/PDMR Shareholding
23rd Feb 20179:36 amRNSInterim Results - Update
23rd Feb 20177:00 amRNSInterim Results
1st Feb 20171:10 pmRNSVoting Rights and Capital
1st Feb 20177:00 amRNSCompletion of Health Service Journal
19th Jan 20177:04 amRNSAcquisition of Health Service Journal
18th Jan 20175:08 pmRNSHolding(s) in Company
17th Jan 20174:43 pmRNSHolding(s) in Company
12th Jan 20179:00 amRNSNotice of Interim Results
3rd Jan 201712:20 pmRNSTotal Voting Rights and Capital
16th Dec 20163:22 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSVoting Rights and Capital
3rd Nov 20164:03 pmRNSResult of AGM
3rd Nov 20167:00 amRNSAGM and Q1 Trading update
1st Nov 20167:00 amRNSVoting Rights and Capital
17th Oct 201612:53 pmRNSHolding(s) in Company
3rd Oct 201610:05 amRNSVoting Rights and Capital
21st Sep 20162:48 pmRNSDirector/PDMR Shareholdings
20th Sep 201611:54 amRNSShare Awards
16th Sep 20164:31 pmRNSReplacement: Share Awards and Options
16th Sep 20169:10 amRNSShare Awards and Options
14th Sep 20167:00 amRNSFinal Results
2nd Sep 20161:48 pmRNSHolding(s) in Company
1st Sep 20169:39 amRNSVoting Rights and Capital
11th Aug 201610:31 amRNSNotice of Final Results
1st Aug 20169:44 amRNSVoting Rights and Capital
21st Jul 20169:41 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSAcquisition of SWAT
1st Jul 20167:00 amRNSVoting Rights and Capital
10th Jun 20165:04 pmRNSHolding(s) in Company
1st Jun 201611:55 amRNSVoting Rights and Capital
23rd May 201611:57 amRNSHolding(s) in Company
12th May 20167:00 amRNSInterim Management Statement
4th May 20164:05 pmRNSHolding(s) in Company
4th May 20163:54 pmRNSHolding(s) in Company
3rd May 201610:03 amRNSTotal Voting Rights
29th Apr 20169:33 amRNSChange of Company Secretary
1st Apr 20169:33 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAcquisition
18th Mar 20163:10 pmRNSHolding(s) in Company
11th Mar 20162:03 pmRNSDirector/PDMR Shareholding
1st Mar 20164:37 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSInterim Results
1st Feb 20169:37 amRNSTotal Voting Rights
19th Jan 20167:00 amRNSAcquisition
15th Jan 20169:52 amRNSHolding(s) in Company
12th Jan 201610:54 amRNSNotification of Interim Results
4th Jan 201611:12 amRNSTotal Voting Rights
17th Dec 20157:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.